Jens Kemp - 07 May 2026 Form 4 Insider Report for Axogen, Inc. (AXGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 May 2026, 16:07:03 UTC
Prior SEC filing
02 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Marc Began, as attorney-in-fact for Jens Kemp

Key filing fact

Jens Kemp filed Form 4 for Axogen, Inc. (AXGN) on 08 May 2026.

Key facts

  • This page summarizes Jens Kemp's Form 4 filing for Axogen, Inc. (AXGN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 May 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 02 Mar 2026.
  • Current net transaction value: -$173,761.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002007485 Primary reporting owner

Kemp Jens

Relationship
Chief Marketing Officer
Address
13631 PROGRESS BLVD.,, SUITE 400, ALACHUA
Signature
Marc Began, as attorney-in-fact for Jens Kemp
Signature date
08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Sale

Transaction value
$173,761
Shares
-4,000
Change %
-5.2%
Price
$43.44
Shares after
72,451
Date
07 May 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.44 to $43.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .